Tim Roberts, Chief Commercial Officer, sat down with Pharma’s Almanac’s Scientific Editor in Chief David Alvaro to discuss the advancements in oncology, the impact of COVID-19 on the industry, and why PCI is well-positioned to be a successful company
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Start your PCI experience today.Your bridge between life-changing therapies and patients.